Verition Fund Management’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-54,893
Closed -$187K 2998
2025
Q4
$187K Buy
54,893
+21,004
+62% +$102K ﹤0.01% 3190
2025
Q3
$230K Sell
33,889
-84,715
-71% -$700K ﹤0.01% 3420
2025
Q2
$1.62M Buy
+118,604
New +$1.12M 0.01% 2108
2025
Q1
Sell
-13,900
Closed -$68.8K 3533
2024
Q4
$68.8K Sell
13,900
-17,610
-56% -$92.3K ﹤0.01% 3110
2024
Q3
$165K Sell
31,510
-28,375
-47% -$164K ﹤0.01% 2927
2024
Q2
$411K Buy
59,885
+17,600
+42% +$161K ﹤0.01% 2164
2024
Q1
$435K Buy
42,285
+13,589
+47% +$100K ﹤0.01% 2087
2023
Q4
$238K Buy
+28,696
New +$206K ﹤0.01% 1926

Other funds holding LFMD

Verition Fund Management's LFMD Position: Q1 2026 in Review

Verition Fund Management sold out of LifeMD (LFMD) in Q1 2026, closing a stake of 54,893 shares — an estimated $187K sold.

Verition Fund Management first reported a position in LFMD in Q4 2023 and held it in 8 quarters. The position peaked at $1.62M in Q2 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • Verition Fund Management reported no remaining LifeMD position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 54,893 LifeMD shares in Q1 2026, an estimated $187K.
  • Verition Fund Management first reported a position in LifeMD in Q4 2023 and held it in 8 quarters.
  • Verition Fund Management's LifeMD position peaked at $1.62M in Q2 2025.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.